ArticleKidney international reports2026

Balancing Benefits and Risks of Rituximab in Pediatric Idiopathic Nephrotic Syndrome: The Critical Role of Age.

Koichi NakanishiPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.